Candia, Teresita R.

HRN: 27-10-75  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/09/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/09/2026
01/16/2026
IVT
2.25g
Q6
Dm Foot
Checking Initial Appropriateness 

 Indication:  Empirical Escalation    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines